Search results
Results from the WOW.Com Content Network
Rapid weight loss increases risk of gallstones. [27] The weight loss drug orlistat is known to increase the risk of gallstones. [28] Cholecystokinin deficiency caused by celiac disease increases risk of gallstone formation, especially when diagnosis of celiac disease is delayed. [29] Pigment gallstones are most commonly seen in the developing ...
Biliary sludge has been associated with pregnancy, rapid weight loss, total parenteral nutrition, drugs such as ceftriaxone and octreotide, solid organ transplantation, and gastric surgery. [1] [2] In many of these conditions, it is thought that the impairment in the contractility of the gallbladder leads to the formation of the sludge. [2]
Cancer of the gallbladder can cause attacks of biliary pain, yellowing of the skin , and weight loss. A large gallbladder may be able to be felt in the abdomen. Liver function tests may be elevated, particularly involving GGT and ALP, with ultrasound and CT scans being considered medical imaging investigations of choice. [21]
Gallbladder problems. ... “The Depo-Provera shot works to suppress ovulation and has been associated with bloating or weight gain in some women, but I have had some patients notice green poop ...
Biliary colic, also known as symptomatic cholelithiasis, a gallbladder attack or gallstone attack, is when a colic (sudden pain) occurs due to a gallstone temporarily blocking the cystic duct. [1] Typically, the pain is in the right upper part of the abdomen , and can be severe. [ 2 ]
Weight loss is a personal for everyone, so it’s hard to say that you’ll drop pounds just by having more protein and fiber in your diet. However, eating both may help you feel fuller for longer.
Gallbladder diseases are diseases involving the gallbladder and is closely linked to biliary disease, with the most common cause being gallstones (cholelithiasis). [1] [2]The gallbladder is designed to aid in the digestion of fats by concentrating and storing the bile made in the liver and transferring it through the biliary tract to the digestive system through bile ducts that connect the ...
PHOTO: Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk is seen on Oct. 16, 2024. (James Manning/PA Images via Getty Images)